CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Return to article

Table 2 Effect of dnPLK1 on cdk1 kinase activity

Cyclin B1 antibody was used to immunoprecipitate cdk1 from control and from dnPLK1 Ad-infected cells prepared as above for cdc25C phosphorylation status. cdk1 activity against Histone H1 substrate was determined.

Cell line Cdk1 kinase activity results:

Phenotype MOI Time (h) % inhibition

HMEC Nonsensitive 500 48 98
U-20S Sensitive 500 24 88
MCF7 Nonsensitive 650 24 85





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation